Interestingly, in both primary and distant tumours, the infiltration levels of CD3+, CD4+ and CD8+ T cells were substantially higher in the BP plus aCD47 combination treatment group than in the control groups (Fig. 7i–l), revealing the adaptive immunological responses triggered in distant metastases as well. This evidence concerns the gene CD8A and neoplasm.